Global Information
회사소개 | 문의 | 비교리스트

소분자 API(원료의약품) 시장 : 규모, 점유율, 전망, 기회 분석(2018-2026년)

Small Molecule API Market - Size, Share, Outlook, and Opportunity Analysis, 2018- 2026

리서치사 Coherent Market Insights
발행일 2019년 04월 상품 코드 833143
페이지 정보 영문
가격
US $ 4,500 ₩ 5,347,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,318,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,884,000 PPT Turned PDF (Enterprise User License)


소분자 API(원료의약품) 시장 : 규모, 점유율, 전망, 기회 분석(2018-2026년) Small Molecule API Market - Size, Share, Outlook, and Opportunity Analysis, 2018- 2026
발행일 : 2019년 04월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

소분자 API(원료의약품)은 저분자량 유기 화합물이며, 이것은 생물학적 프로세스를 제어하는 데 도움이 됩니다. 대부분 소분자는 경구투여할 수 있고, 몸에 흡수될 가능성이 가장 높으며, 크기가 작으므로 세포내 작용 부위에 도달하는 급속 확산성 성질을 가지고 있습니다.

세계의 소분자 API(원료의약품) 시장을 조사했으며, 시장 개요, 종류 및 지역별 시장 동향, 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인, 시장 기회 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 범위

  • 보고서에 대해
    • 시장 정의와 범위
  • 주요 요약
    • API 종류별 시장
    • 카테고리별 시장
    • 지역별 시장
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 해석
  • PEST 분석
  • 협업, 인수합병(M&A)
  • 규제 시나리오
  • 기술 발전
  • 소분자 API 제조 순서
  • 소분자 API 주요 공급업체
  • 시장 동향

제4장 API 종류별 시장, 2018-2026년(백만 달러)

  • 서론
  • 인공
  • 천연

제5장 카테고리별 시장, 2018-2026년(백만 달러)

  • 서론
  • 진통제
  • 마취제
  • 항경련제
  • 대사길항제
  • 항균
  • 알킬화제
  • 기타

제6장 지역별 시장, 2018-2026년(백만 달러)

  • 서론
  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제7장 경쟁 환경

  • 히트 맵 분석
  • 기업 개요
    • Lonza
      • API 종류 포트폴리오
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer, Inc.
    • Aesica Pharmaceuticals Ltd.
    • Albemarle Corporation
    • Cambrex Corporation
    • BASF SE
    • Gland Pharma Limited
    • Gilead Sciences, Inc.
    • AstraZeneca Plc
    • BASF SE
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Celgene Corporation
    • Piramal Pharma Solutions
    • Recipharm AB
    • Evonik Industries AG
    • Glenmark Pharmaceuticals Limited
    • Siegfried AG
    • AbbVie Contract Manufacturing
    • Aurinia Pharmaceuticals Inc.
    • Bayer AG
    • Patheon
    • CordenPharma International
  • 애널리스트의 견해

제8장 섹션

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights에 대해
LSH 19.05.20

A small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process. Most of the small molecules can be administered orally and are most likely to be absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach the intracellular site of action.

Market Dynamics

Growing expansion of small molecule API manufacturers in the Asia Pacific region is a major factor driving the small molecule API market growth. For instance, BASF is planning to build a new specialty amines plant at its existing site in Nanjing Chemical Industry Park, China. This new multi-product plant will be able to manufacture 21,000 metric tons of amines year, and it extends BASF's amines portfolio at the specialty amines complex in Nanjing. The plant is scheduled to stream by 2019. Moreover the small molecule API manufacturers have planned to add global sales and business development staff, followed by quality, regulatory, and project management teams, which have positively influenced growth of the market.

However, stringent regulatory policies for API manufacturing may hinder the market growth. Stringent global regulatory policies on quality assessments of small molecule API manufacturing, facility certification, and increased supply chain security issues across emerging countries have a large impact on the cost of final small molecule API products. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges, owing to aforementioned factors.

Key features of the study:

  • This report provides in-depth analysis of the small molecule API market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, impact analysis, PEST analysis, collaborations, mergers and acquisitions, regulatory scenarios, technological advancements, steps to manufacture small molecule API, major suppliers of small molecule APIs, market trends
  • It profiles key players in the global small molecule API market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Lonza, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Aesica Pharmaceuticals Ltd., Albemarle Corporation, Cambrex Corporation, BASF SE, Gland Pharma Limited, Gilead Sciences, Inc., AstraZeneca Plc, Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Piramal Pharma Solutions, Recipharm AB, Evonik Industries AG, Glenmark Pharmaceuticals Limited, Siegfried AG, AbbVie Contract Manufacturing, Aurinia Pharmaceuticals Inc., Bayer AG, Patheon, CordenPharma International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global small molecule API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the small molecule API market

Detailed Segmentation:

  • Global Small Molecule API Market, By API Type:
    • Artificial
    • Natural
  • Global Small Molecule API Market, By Category:
    • Analgesic
    • Anesthetics
    • Anticonvulsants
    • Antimetabolites
    • Antibacterial
    • Alkylating Agents
    • Others
  • Global Small Molecule API Market, By Geography:
    • North America
      • By API Type:
      • Artificial
      • Natural
      • By Category:
      • Analgesic
      • Anesthetics
      • Anticonvulsants
      • Antimetabolites
      • Antibacterial
      • Alkylating Agents
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By API Type:
      • Artificial
      • Natural
      • By Category:
      • Analgesic
      • Anesthetics
      • Anticonvulsants
      • Antimetabolites
      • Antibacterial
      • Alkylating Agents
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By API Type:
      • Artificial
      • Natural
      • By Category:
      • Analgesic
      • Anesthetics
      • Anticonvulsants
      • Antimetabolites
      • Antibacterial
      • Alkylating Agents
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By API Type:
      • Artificial
      • Natural
      • By Category:
      • Analgesic
      • Anesthetics
      • Anticonvulsants
      • Antimetabolites
      • Antibacterial
      • Alkylating Agents
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By API Type:
      • Artificial
      • Natural
      • By Category:
      • Analgesic
      • Anesthetics
      • Anticonvulsants
      • Antimetabolites
      • Antibacterial
      • Alkylating Agents
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By API Type:
      • Artificial
      • Natural
      • By Category:
      • Analgesic
      • Anesthetics
      • Anticonvulsants
      • Antimetabolites
      • Antibacterial
      • Alkylating Agents
      • Others
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Lonza *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Pfizer, Inc.
    • Aesica Pharmaceuticals Ltd.
    • Albemarle Corporation
    • Cambrex Corporation
    • BASF SE
    • Gland Pharma Limited
    • Gilead Sciences, Inc.
    • AstraZeneca Plc
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Celgene Corporation
    • Piramal Pharma Solutions
    • Recipharm AB
    • Evonik Industries AG
    • Glenmark Pharmaceuticals Limited
    • Siegfried AG
    • AbbVie Contract Manufacturing
    • Aurinia Pharmaceuticals Inc.
    • Bayer AG
    • Patheon
    • CordenPharma International
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By API Type
    • Market Snippet, By Category
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • PEST Analysis
  • Collaborations, Mergers and Acquisitions
  • Regulatory Scenario
  • Technological Advancements
  • Steps to Manufacture Small Molecule API
  • Major Suppliers of Small Molecule APIs
  • Market Trends

4. Global Small Molecule API Market, By API Type, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Artificial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Natural
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Small Molecule API Market, By Category, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Analgesic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Anticonvulsants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Antimetabolites
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Antibacterial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Alkylating Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Small Molecule API Market, By Region, 2018 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By API Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Category, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By API Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Category, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By API Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Category, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By API Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Category, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By API Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Category, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By API Type, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Category, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Lonza
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer, Inc.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aesica Pharmaceuticals Ltd.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Albemarle Corporation
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cambrex Corporation
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BASF SE
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gland Pharma Limited
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gilead Sciences, Inc.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca Plc
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BASF SE
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Baxter International Inc.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim International GmbH
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Celgene Corporation
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Piramal Pharma Solutions
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Recipharm AB
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Evonik Industries AG
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Glenmark Pharmaceuticals Limited
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Siegfried AG
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Contract Manufacturing
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aurinia Pharmaceuticals Inc.
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bayer AG
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Patheon
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CordenPharma International
    • Company Overview
    • API Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q